#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dermatitis atopic Breast cancer metastatic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Undifferentiated sarcoma Glomerulonephritis acute Oesophageal adenocarcinoma Essential thrombocythaemia Breast angiosarcoma metastatic Infertility male X-linked lymphoproliferative syndrome Acute myeloid leukaemia recurrent Arteriovenous malformation Nasopharyngeal cancer Hyperphagia Immunodeficiency common variable Meningococcal immunisation Albright's disease Prodromal Alzheimer's disease More trials…

    Learn about Rare Diseases

    Waldenstrom’s macroglobulinaemia Mastocytosis – Treatment Activated PI3 kinase delta syndrome – Basic Information Activated PI3 kinase delta syndrome – Diagnostics Stevens-Johnson syndrome – Life with Disease Sarcoidosis – Life with Disease Brain stem glioma – Diagnostics Mast cell activation syndrome – Treatment Bronchopulmonary dysplasia – Life with Disease Adrenocortical carcinoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    IBUZATRELVIR Ritonavir Molidustat Sodium DCC-3084 Cobolimab Lamivudine Gs-1427 Ab-1002 Encorafenib Brentuximab Vedotin SP16 Teprotumumab Ck-0045 Ferric Derisomaltose Milnacipran Hydrochloride Immunoglobulin M Atropine Sulfate Islatravir Azd5863 Tildrakizumab More therapies…

    Learn about Your Condition

    Chronic myeloid leukaemia Arrhythmia supraventricular Rectal cancer Renal cell carcinoma stage IV Infertility female Myotonic dystrophy Colon cancer stage III Lupus nephritis Pseudomonas infection Congenital myopathy Mucopolysaccharidosis Deafness traumatic Primary biliary cholangitis Spina bifida Metabolic syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

ABM

  • Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cerebral amyloid angiopathy
    • Dementia Alzheimer’s type
    • Parkinson’s disease
    Investigated Drugs:
    • [18F]Mc225
    The Netherlands

  • Study on Anakinra for Children with Systemic Juvenile Idiopathic Arthritis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Still’s disease
    • Juvenile idiopathic arthritis
    Investigated Drugs:
    • Anakinra
    The Netherlands

  • Study on the Effects of Rintatolimod After FOLFIRINOX in Patients with Locally Advanced Pancreatic Cancer

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Pancreatic carcinoma
    Investigated Drugs:
    • Rintatolimod
    The Netherlands

  • Study on Dapagliflozin for Patients with Chronic Kidney Disease or Kidney Failure Undergoing Hemodialysis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Haemodialysis
    • Chronic kidney disease
    • Renal failure
    Investigated Drugs:
    • Dapagliflozin
    Austria

  • Study on the Safety and Effectiveness of Sodium Chloride and Bacteriophage for Treating Surgical Wound Infections in Patients

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Postoperative wound infection
    Investigated Drugs:
    • Sodium Chloride
    Czechia

  • Study on the Effectiveness and Safety of Cytarabine, Tafasitamab, and Lenalidomide for Patients with Relapsed Diffuse Large B-Cell Lymphoma

    Not yet recruiting

    2 1 1 1
    Investigated Drugs:
    • Axicabtagene Ciloleucel
    • Cisplatin
    • Cytarabine
    Poland
Previous Page
1 … 827 828 829 830 831 … 1,657
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!